
### [NCIT:C7539](http://purl.obolibrary.org/obo/NCIT_C7539)
**Label:** Lymphoid Leukemia

**Subclasses:** [NCIT:C4752](http://purl.obolibrary.org/obo/NCIT_C4752) (T-Cell Prolymphocytic Leukemia), [NCIT:C4753](http://purl.obolibrary.org/obo/NCIT_C4753) (B-Cell Prolymphocytic Leukemia), [NCIT:C7300](http://purl.obolibrary.org/obo/NCIT_C7300) (Splenic Manifestation of Chronic Lymphocytic Leukemia), [NCIT:C7784](http://purl.obolibrary.org/obo/NCIT_C7784) (Recurrent Childhood Acute Lymphoblastic Leukemia), [NCIT:C3183](http://purl.obolibrary.org/obo/NCIT_C3183) (T Acute Lymphoblastic Leukemia), [NCIT:C7302](http://purl.obolibrary.org/obo/NCIT_C7302) (Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia), [NCIT:C7301](http://purl.obolibrary.org/obo/NCIT_C7301) (Splenic Manifestation of Hairy Cell Leukemia), [NCIT:C3181](http://purl.obolibrary.org/obo/NCIT_C3181) (Prolymphocytic Leukemia), [NCIT:C8594](http://purl.obolibrary.org/obo/NCIT_C8594) (Leukemic Phase of Lymphoma), [NCIT:C128629](http://purl.obolibrary.org/obo/NCIT_C128629) (B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative), [NCIT:C134835](http://purl.obolibrary.org/obo/NCIT_C134835) (Refractory Ph-Like Acute Lymphoblastic Leukemia), [NCIT:C134834](http://purl.obolibrary.org/obo/NCIT_C134834) (Recurrent Ph-Like Acute Lymphoblastic Leukemia), [NCIT:C4967](http://purl.obolibrary.org/obo/NCIT_C4967) (Adult Acute Lymphoblastic Leukemia), [NCIT:C8647](http://purl.obolibrary.org/obo/NCIT_C8647) (Aggressive NK-Cell Leukemia), [NCIT:C7953](http://purl.obolibrary.org/obo/NCIT_C7953) (Childhood T Acute Lymphoblastic Leukemia), [NCIT:C7876](http://purl.obolibrary.org/obo/NCIT_C7876) (Stage III Chronic Lymphocytic Leukemia), [NCIT:C7952](http://purl.obolibrary.org/obo/NCIT_C7952) (Childhood Burkitt Leukemia), [NCIT:C7875](http://purl.obolibrary.org/obo/NCIT_C7875) (Stage II Chronic Lymphocytic Leukemia), [NCIT:C136488](http://purl.obolibrary.org/obo/NCIT_C136488) (Refractory Acute Lymphoblastic Leukemia), [NCIT:C8645](http://purl.obolibrary.org/obo/NCIT_C8645) (Recurrent Chronic Lymphocytic Leukemia), [NCIT:C8646](http://purl.obolibrary.org/obo/NCIT_C8646) (Stage IV Chronic Lymphocytic Leukemia), [NCIT:C7954](http://purl.obolibrary.org/obo/NCIT_C7954) (Adult Burkitt Leukemia), [NCIT:C122617](http://purl.obolibrary.org/obo/NCIT_C122617) (Infant Acute Lymphoblastic Leukemia with MLL Rearrangement), [NCIT:C8644](http://purl.obolibrary.org/obo/NCIT_C8644) (B Acute Lymphoblastic Leukemia), [NCIT:C7874](http://purl.obolibrary.org/obo/NCIT_C7874) (Stage I Chronic Lymphocytic Leukemia), [NCIT:C122614](http://purl.obolibrary.org/obo/NCIT_C122614) (Infant Acute Lymphoblastic Leukemia), [NCIT:C39586](http://purl.obolibrary.org/obo/NCIT_C39586) (T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta), [NCIT:C9142](http://purl.obolibrary.org/obo/NCIT_C9142) (Adult T Acute Lymphoblastic Leukemia), [NCIT:C138192](http://purl.obolibrary.org/obo/NCIT_C138192) (Leukemic Nonnodal Mantle Cell Lymphoma), [NCIT:C36272](http://purl.obolibrary.org/obo/NCIT_C36272) (Chronic Lymphocytic Leukemia with Plasmacytoid Differentiation), [NCIT:C9140](http://purl.obolibrary.org/obo/NCIT_C9140) (Childhood B Acute Lymphoblastic Leukemia), [NCIT:C36271](http://purl.obolibrary.org/obo/NCIT_C36271) (T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant), [NCIT:C37202](http://purl.obolibrary.org/obo/NCIT_C37202) (Chronic Lymphocytic Leukemia with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation), [NCIT:C39584](http://purl.obolibrary.org/obo/NCIT_C39584) (T-Cell Large Granular Lymphocyte Leukemia, Common Variant), [NCIT:C131875](http://purl.obolibrary.org/obo/NCIT_C131875) (Recurrent Childhood T Acute Lymphoblastic Leukemia), [NCIT:C36312](http://purl.obolibrary.org/obo/NCIT_C36312) (B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C37205](http://purl.obolibrary.org/obo/NCIT_C37205) (Chronic Lymphocytic Leukemia with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene), [NCIT:C7847](http://purl.obolibrary.org/obo/NCIT_C7847) (Stage 0 Chronic Lymphocytic Leukemia), [NCIT:C80347](http://purl.obolibrary.org/obo/NCIT_C80347) (B Acute Lymphoblastic Leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)), [NCIT:C3366](http://purl.obolibrary.org/obo/NCIT_C3366) (Sezary Syndrome), [NCIT:C3168](http://purl.obolibrary.org/obo/NCIT_C3168) (Childhood Acute Lymphoblastic Leukemia), [NCIT:C80346](http://purl.obolibrary.org/obo/NCIT_C80346) (B Acute Lymphoblastic Leukemia with t(5;14)(q31.1;q32.3); IL3-IGH), [NCIT:C3167](http://purl.obolibrary.org/obo/NCIT_C3167) (Acute Lymphoblastic Leukemia), [NCIT:C80345](http://purl.obolibrary.org/obo/NCIT_C80345) (Hypodiploid B Acute Lymphoblastic Leukemia), [NCIT:C80344](http://purl.obolibrary.org/obo/NCIT_C80344) (Hyperdiploid B Acute Lymphoblastic Leukemia), [NCIT:C7402](http://purl.obolibrary.org/obo/NCIT_C7402) (Hairy Cell Leukemia), [NCIT:C7886](http://purl.obolibrary.org/obo/NCIT_C7886) (Refractory Chronic Lymphocytic Leukemia), [NCIT:C80343](http://purl.obolibrary.org/obo/NCIT_C80343) (B Acute Lymphoblastic Leukemia with t(12;21)(p13.2;q22.1); ETV6-RUNX1), [NCIT:C80342](http://purl.obolibrary.org/obo/NCIT_C80342) (B Acute Lymphoblastic Leukemia with t(v;11q23.3); KMT2A Rearranged), [NCIT:C45264](http://purl.obolibrary.org/obo/NCIT_C45264) (Cutaneous Chronic Lymphocytic Leukemia), [NCIT:C7883](http://purl.obolibrary.org/obo/NCIT_C7883) (Recurrent Adult Acute Lymphoblastic Leukemia), [NCIT:C121978](http://purl.obolibrary.org/obo/NCIT_C121978) (Acute Lymphoblastic Leukemia by ROSE Cluster), [NCIT:C7401](http://purl.obolibrary.org/obo/NCIT_C7401) (Hairy Cell Leukemia Variant), [NCIT:C7400](http://purl.obolibrary.org/obo/NCIT_C7400) (Burkitt Leukemia), [NCIT:C121975](http://purl.obolibrary.org/obo/NCIT_C121975) (DDIT4L Acute Lymphoblastic Leukemia), [NCIT:C122624](http://purl.obolibrary.org/obo/NCIT_C122624) (Refractory Childhood Acute Lymphoblastic Leukemia), [NCIT:C36270](http://purl.obolibrary.org/obo/NCIT_C36270) (T-Cell Prolymphocytic Leukemia, Small Cell Variant), [NCIT:C126309](http://purl.obolibrary.org/obo/NCIT_C126309) (Refractory Adult Acute Lymphoblastic Leukemia), [NCIT:C9143](http://purl.obolibrary.org/obo/NCIT_C9143) (Adult B Acute Lymphoblastic Leukemia), [NCIT:C3163](http://purl.obolibrary.org/obo/NCIT_C3163) (Chronic Lymphocytic Leukemia), [NCIT:C122621](http://purl.obolibrary.org/obo/NCIT_C122621) (Infant Acute Lymphoblastic Leukemia without KMT2A Gene Rearrangement), [NCIT:C68659](http://purl.obolibrary.org/obo/NCIT_C68659) (Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C121974](http://purl.obolibrary.org/obo/NCIT_C121974) (Ph-Like Acute Lymphoblastic Leukemia), [NCIT:C121973](http://purl.obolibrary.org/obo/NCIT_C121973) (Acute Lymphoblastic Leukemia by Gene Expression Profile), [NCIT:C5631](http://purl.obolibrary.org/obo/NCIT_C5631) (Aleukemic Acute Lymphoblastic Leukemia Cutis), [NCIT:C4664](http://purl.obolibrary.org/obo/NCIT_C4664) (T-Cell Large Granular Lymphocyte Leukemia), [NCIT:C8029](http://purl.obolibrary.org/obo/NCIT_C8029) (Progressive Hairy Cell Leukemia Initial Treatment), [NCIT:C7299](http://purl.obolibrary.org/obo/NCIT_C7299) (Splenic Manifestation of B-Cell Prolymphocytic Leukemia), [NCIT:C4343](http://purl.obolibrary.org/obo/NCIT_C4343) (Aleukemic Lymphoid Leukemia), [NCIT:C7177](http://purl.obolibrary.org/obo/NCIT_C7177) (Aleukemic Acute Lymphoblastic Leukemia), [NCIT:C7298](http://purl.obolibrary.org/obo/NCIT_C7298) (Splenic Manifestation of T-Cell Prolymphocytic Leukemia), [NCIT:C7176](http://purl.obolibrary.org/obo/NCIT_C7176) (Aleukemic Chronic Lymphocytic Leukemia), [NCIT:C7297](http://purl.obolibrary.org/obo/NCIT_C7297) (Splenic Manifestation of Prolymphocytic Leukemia), [NCIT:C8030](http://purl.obolibrary.org/obo/NCIT_C8030) (Refractory Hairy Cell Leukemia), [NCIT:C3180](http://purl.obolibrary.org/obo/NCIT_C3180) (Plasma Cell Leukemia), [NCIT:C114819](http://purl.obolibrary.org/obo/NCIT_C114819) (Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1), [NCIT:C126112](http://purl.obolibrary.org/obo/NCIT_C126112) (Infant T Acute Lymphoblastic Leukemia), 

**Class expressions from DL-Learner:**

- Thing 52.77%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39961](http://purl.obolibrary.org/obo/NCIT_C39961) (Penile Basal Cell Carcinoma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39959](http://purl.obolibrary.org/obo/NCIT_C39959) (Mixed Squamous Cell Carcinoma of the Penis))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39957](http://purl.obolibrary.org/obo/NCIT_C39957) (Epididymal Adenocarcinoma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39956](http://purl.obolibrary.org/obo/NCIT_C39956) (Rete Testis Adenoma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3994](http://purl.obolibrary.org/obo/NCIT_C3994) (Stage IV Colon Cancer AJCC v6))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3993](http://purl.obolibrary.org/obo/NCIT_C3993) (Stage II Colon Cancer AJCC v6))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 39.52%


